ALB and osteoarthritis: The low molecular weight fraction of human serum albumin (LMWF5A) is a novel anti-inflammatory biologic drug that has demonstrated clinical efficacy with reduced pain and improved function in osteoarthritis of the knee, a chronic inflammatory condition, across multiple randomized, vehicle-controlled, double-blinded human trials [18–20].